Novartis India Limited

NOVARTIND.BO

NOVARTIND.BONovartis India Limited IN flag

Bombay Stock Exchange

885.05

INR

+15.30

(+1.76%)

34.96EPS

25.32P/E

21.85BMarket Cap

May 09Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

INE234A01025

Return %

Stock

S&P500

-18.81

12.11

47.59

52.58

59.34

103.52

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	264.16	282.65	269.78	273.27	215.82	203.45	187.63	182.39	166.6	148.08	156.97	149.49	135.29	142.81
Basic EPS, GAAP	47.56	37.46	30.83	24.75	62.04	19.1	28.43	20.97	4.08	8.46	-1.51	41.86	34.5	34.95
Free Cash Flow per Basic Share	21.97	1.12	-1.88	-20.11	16.93	-14.56	58.12	-84.38	-9.78	-28.07	15.46	18.02	45.93	- -
Dividend per Share	9.99	9.99	10.02	9.98	9.97	10.66	10.17	10.02	10	10	10	10	47.5	- -
Book Value per Share	146.86	168.88	184.92	209.71	259.8	282.92	267.08	307.73	291.76	287.76	279.57	312.69	300.18	- -
Tangible Book Value per Share	255.88	281.65	300.79	323.25	373.45	306.94	266.16	307.48	291.9	288.04	280.14	314.15	301.66	- -
Basic Weighted Avg Shares	32	32	32	32	32	30	28	25	25	25	25	25	25	25
Sales/Revenue/Turnover	8,443	9,034	8,622	8,734	6,898	6,096	5,172	4,503	4,114	3,656	3,876	3,691	3,340	3,525
Operating Margin (%)	17.18	9.87	0.2	1.65	5.06	3.97	-1.24	2.94	0.31	4.11	4.49	18.76	19.54	22.52
Depreciation Expense	27	36	36	40	35	36	25	32	131	122	96	61	26	18
Net Income, GAAP	1,520	1,197	985	791	1,983	572	784	518	101	209	-37	1,034	852	863
Effective Tax Rate (%)	32.34	29.33	- -	13.64	34.91	37.62	50.25	39.64	64.8	47.8	- -	10.42	30.65	26.8
Profit Margin (%)	18.01	13.25	11.43	9.06	28.75	9.39	15.15	11.5	2.45	5.72	-0.96	28	25.5	24.47
Working Capital	7,396	8,213	8,489	9,308	10,592	7,883	6,225	6,215	5,803	5,651	4,923	5,178	5,421	- -
LT Debt	1	- -	- -	- -	- -	- -	- -	- -	565	498	183	174	51	- -
Total Equity	8,179	9,002	9,614	10,331	11,936	9,196	7,336	7,592	7,207	7,112	6,917	7,757	7,448	- -
Return on Invested Capital (%)	12.9	7.33	- -	1.25	2.03	1.42	-0.38	1.04	0.06	0.99	- -	8.08	5.76	- -
Return on Capital (%)	25.99	23.73	- -	12.54	26.45	6.87	10.24	7.05	1.59	3.19	- -	13.92	11.19	459.69
Return on Common Equity (%)	25.93	23.73	17.43	12.54	26.43	6.82	9.89	6.92	1.36	2.92	-0.53	14.14	11.26	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	-8.75%	-5.61%	-9.5%
Net Income, GAAP	-292.42%	-597.41%	-17.58%
Free Cash Flow	2.26%	23.01%	154.89%
Total Cash Common Dividend	- -	- -	375.01%
Total Equity	-1.77%	-0.19%	-3.98%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Dr. Vasant Narasimhan M.D.
Full Time Employees: 62
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Address: Inspire BKC Mumbai India 400051
IPO Date: Jan 3, 2000
Website: novartis.in
Similar Companies: Agile Therapeutics, Inc. (AGRX)
Hyundai Pharmaceutical Co., Ltd. (004310.KS)
Heritage Cannabis Holdings Corp. (CANN.CN)
Vitura Health Limited (VIT.AX)
Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)
Captiva Verde Wellness Corp. (PWR.CN)
Business: Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.

	Jun'25	Sep'25	Dec'25
Total Current Assets	- -	6,953	- -
Accounts Receivable, Net	- -	381	- -
Cash, Cash Equivalents & STI	- -	5,977	- -
Inventories	- -	336	- -
Total Current Liabilities	- -	1,402	- -
Payables & Accruals	- -	- -	- -
ST Debt	- -	20	- -
Deferred Revenue	- -	- -	- -

	Jun'25	Sep'25	Dec'25
ST Debt	- -	20	- -
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	41	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	- -	25	- -
Market Capitalization	26,683	27,629	22,705

Year	Q1	Q2	Q3	Q4	FY
2023	1,209	1,015	802	665	3,691
2024	906	788	845	801	3,340
2025	923	871	930	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	- -	- -	- -	- -	10
2024	- -	- -	- -	- -	47.5
2025	- -	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	21.21	7.43	3.08	- -	41.86
2024	8.21	9.59	10.76	- -	34.5
2025	10.42	8.27	10.31	- -	- -

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	264.16	282.65	269.78	273.27	215.82	203.45	187.63	182.39	166.6	148.08	156.97	149.49	135.29	142.81
Basic EPS, GAAP	47.56	37.46	30.83	24.75	62.04	19.1	28.43	20.97	4.08	8.46	-1.51	41.86	34.5	34.95
Free Cash Flow per Basic Share	21.97	1.12	-1.88	-20.11	16.93	-14.56	58.12	-84.38	-9.78	-28.07	15.46	18.02	45.93	- -
Dividend per Share	9.99	9.99	10.02	9.98	9.97	10.66	10.17	10.02	10	10	10	10	47.5	- -
Book Value per Share	146.86	168.88	184.92	209.71	259.8	282.92	267.08	307.73	291.76	287.76	279.57	312.69	300.18	- -
Tangible Book Value per Share	255.88	281.65	300.79	323.25	373.45	306.94	266.16	307.48	291.9	288.04	280.14	314.15	301.66	- -
Basic Weighted Avg Shares	32	32	32	32	32	30	28	25	25	25	25	25	25	25
Sales/Revenue/Turnover	8,443	9,034	8,622	8,734	6,898	6,096	5,172	4,503	4,114	3,656	3,876	3,691	3,340	3,525
Operating Margin (%)	17.18	9.87	0.2	1.65	5.06	3.97	-1.24	2.94	0.31	4.11	4.49	18.76	19.54	22.52
Depreciation Expense	27	36	36	40	35	36	25	32	131	122	96	61	26	18
Net Income, GAAP	1,520	1,197	985	791	1,983	572	784	518	101	209	-37	1,034	852	863
Effective Tax Rate (%)	32.34	29.33	- -	13.64	34.91	37.62	50.25	39.64	64.8	47.8	- -	10.42	30.65	26.8
Profit Margin (%)	18.01	13.25	11.43	9.06	28.75	9.39	15.15	11.5	2.45	5.72	-0.96	28	25.5	24.47
Working Capital	7,396	8,213	8,489	9,308	10,592	7,883	6,225	6,215	5,803	5,651	4,923	5,178	5,421	- -
LT Debt	1	- -	- -	- -	- -	- -	- -	- -	565	498	183	174	51	- -
Total Equity	8,179	9,002	9,614	10,331	11,936	9,196	7,336	7,592	7,207	7,112	6,917	7,757	7,448	- -
Return on Invested Capital (%)	12.9	7.33	- -	1.25	2.03	1.42	-0.38	1.04	0.06	0.99	- -	8.08	5.76	- -
Return on Capital (%)	25.99	23.73	- -	12.54	26.45	6.87	10.24	7.05	1.59	3.19	- -	13.92	11.19	459.69
Return on Common Equity (%)	25.93	23.73	17.43	12.54	26.43	6.82	9.89	6.92	1.36	2.92	-0.53	14.14	11.26	- -

Novartis India Limited

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Working Capital

Capital Structure

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year